Skip to content

Clinical trials

Observational Lung Neoplasms trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Observational Country / region: Poland Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20111
20121
20143
20152
20161
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Not yet recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
AstraZeneca1
Bristol-Myers Squibb1
European Organisation for Research and Treatment of Cancer - EORTC1
Hoffmann-La Roche1
Medical University of Silesia1
National Cancer Institute (NCI)1
Sandoz1
Science and Technology Park, Center of Innovation Technologies for Human Health1
University Hospital, Gasthuisberg1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms12
Breast Neoplasms3
Neoplasms3
Ovarian Neoplasms2
Prostatic Neoplasms2
Urinary Bladder Neoplasms2
Adenoma, Islet Cell1
Anemia1
Carcinoma, Hepatocellular1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.